Deepak Gondaliya
Corporate Officer/Principal bij Emcure Pharmaceuticals Ltd.
Actieve functies van Deepak Gondaliya
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01-07-2013 | - |
Loopbaan van Deepak Gondaliya
Eerdere bekende functies van Deepak Gondaliya
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | - | - |
Opleiding van Deepak Gondaliya
| Hemchandracharya North Gujarat University | Doctorate Degree |
Statistieken
Internationaal
| India | 4 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Beurs
- Insiders
- Deepak Gondaliya
- Ervaring
